IL146432A0 - A tetrapeptide and a pharmaceutical composition containing the same - Google Patents
A tetrapeptide and a pharmaceutical composition containing the sameInfo
- Publication number
- IL146432A0 IL146432A0 IL14643200A IL14643200A IL146432A0 IL 146432 A0 IL146432 A0 IL 146432A0 IL 14643200 A IL14643200 A IL 14643200A IL 14643200 A IL14643200 A IL 14643200A IL 146432 A0 IL146432 A0 IL 146432A0
- Authority
- IL
- Israel
- Prior art keywords
- tetrapeptide
- seq
- proposed
- substance
- glu
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000126 substance Substances 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 3
- 230000002398 geroprotective effect Effects 0.000 abstract 2
- 230000000144 pharmacologic effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 206010063493 Premature ageing Diseases 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052744 lithium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU99108841/14A RU2157233C1 (ru) | 1999-05-11 | 1999-05-11 | Тетрапептид, обладающий геропротекторной активностью, фармакологическое средство на его основе и способ его применения |
| PCT/RU2000/000012 WO2000068255A2 (en) | 1999-05-11 | 2000-01-20 | Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL146432A0 true IL146432A0 (en) | 2002-07-25 |
Family
ID=20219149
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14643200A IL146432A0 (en) | 1999-05-11 | 2000-01-20 | A tetrapeptide and a pharmaceutical composition containing the same |
| IL146432A IL146432A (en) | 1999-05-11 | 2001-11-11 | Tetrapeptide and pharmaceuticalcomposition containing the same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL146432A IL146432A (en) | 1999-05-11 | 2001-11-11 | Tetrapeptide and pharmaceuticalcomposition containing the same |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6727227B1 (xx) |
| EP (1) | EP1179008B1 (xx) |
| JP (1) | JP3902406B2 (xx) |
| AT (1) | ATE321068T1 (xx) |
| AU (1) | AU769847C (xx) |
| CA (1) | CA2373128C (xx) |
| DE (1) | DE60026826T2 (xx) |
| ES (1) | ES2259998T3 (xx) |
| IL (2) | IL146432A0 (xx) |
| RU (1) | RU2157233C1 (xx) |
| WO (1) | WO2000068255A2 (xx) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8680059B2 (en) * | 1998-05-20 | 2014-03-25 | Biotempt B.V. | Oligopeptide acetate and formulations thereof |
| US6844315B2 (en) * | 1998-05-20 | 2005-01-18 | Erasmus Universiteit Rotterdam | Immunoregulator |
| US20030220258A1 (en) | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
| US7175679B2 (en) * | 2001-03-29 | 2007-02-13 | Biotempt B.V. | Oligopeptide treatment of NF-κB mediated inflammation |
| US20040202645A1 (en) * | 2003-04-08 | 2004-10-14 | Khan Nisar Ahmed | Administration of gene-regulatory peptides |
| EP1138692A1 (en) * | 2000-03-29 | 2001-10-04 | Erasmus Universiteit Rotterdam | Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| US20050227925A1 (en) * | 2004-04-08 | 2005-10-13 | Robbert Benner | Compositions capable of reducing elevated blood urea concentration |
| US6921751B1 (en) * | 1998-05-20 | 2005-07-26 | Erasmus Universiteit Rotterdam | Immunoregulator |
| US7358330B2 (en) * | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
| USRE43279E1 (en) | 2000-03-29 | 2012-03-27 | Biotemp B.V. | Compositions capable of reducing elevated blood urea concentration |
| EP1300418A1 (en) | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Gene regulation by oligopeptides |
| US7576174B2 (en) * | 2000-03-29 | 2009-08-18 | Biotempt B.V. | Compositions capable of reducing elevated blood urea concentration |
| RU2161501C1 (ru) * | 2000-06-29 | 2001-01-10 | Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" | Способ получения пептидов, обладающих тканеспецифической активностью, и фармацевтические композиции на их основе |
| WO2002090380A1 (en) * | 2001-04-17 | 2002-11-14 | Sankt-Peterburgskaya Obschestvennaya Organizatsiya 'institut Bioregulyatsii I Gerontologii Czo Ramn' | Tetrapeptide stimulating the retinal function and the method of its application |
| US20080318871A1 (en) * | 2001-12-21 | 2008-12-25 | Khan Nisar A | Treatment of neurological disorders |
| US7501391B2 (en) | 2001-12-21 | 2009-03-10 | Biotempt B.V. | Treatment of transplant survival |
| US20030220261A1 (en) * | 2001-12-21 | 2003-11-27 | Khan Nisar Ahmed | Treatment of iatrogenic disease |
| US20030224995A1 (en) * | 2001-12-21 | 2003-12-04 | Khan Nisar Ahmed | Treatment of burns |
| US7786084B2 (en) * | 2001-12-21 | 2010-08-31 | Biotempt B.V. | Treatment of burns |
| US20040013661A1 (en) * | 2001-12-21 | 2004-01-22 | Gert Wensvoort | Stratification |
| US7560433B2 (en) * | 2001-12-21 | 2009-07-14 | Biotempt B.V. | Treatment of multiple sclerosis (MS) |
| US20030220257A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of trauma |
| US20080242837A1 (en) * | 2001-12-21 | 2008-10-02 | Khan Nisar A | Peptide compositions |
| US7517529B2 (en) * | 2003-04-08 | 2009-04-14 | Biotempt B.V. | Treatment of type I diabetes |
| RU2257910C1 (ru) * | 2003-12-25 | 2005-08-10 | Институт физиологически активных веществ Российской Академии Наук (ИФАВ РАН) | Растительные экстракты, обладающие геропротекторной активностью и средство на их основе |
| RU2257909C1 (ru) * | 2003-12-25 | 2005-08-10 | Институт физиологически активных веществ Российской Академии Наук (ИФАВ РАН) | Концентрат побегов черники и композиции на его основе, обладающие геропротекторной активностью |
| US20090227505A1 (en) * | 2004-01-07 | 2009-09-10 | Biotempt B.V. | Methods and uses for protein breakdown products |
| RU2255757C1 (ru) * | 2004-06-22 | 2005-07-10 | Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" | Пептидное соединение, восстанавливающее функцию органов дыхания |
| RU2255756C1 (ru) * | 2004-06-22 | 2005-07-10 | Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" | Пептидное соединение, восстанавливающее функцию миокарда |
| RU2297215C2 (ru) * | 2005-02-21 | 2007-04-20 | Государственное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет им. акад. И.П. Павлова" МЗ РФ | Антиоксидантное средство для лечения катаракты |
| JP4846799B2 (ja) * | 2005-07-05 | 2011-12-28 | バイオテンプト ベー．フェー． | 腫瘍の治療 |
| EP1864692A1 (en) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
| RU2304444C1 (ru) * | 2006-05-23 | 2007-08-20 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Пептид, обладающий стресспротекторным действием, фармацевтическая композиция на его основе и способ ее применения |
| RU2295970C1 (ru) * | 2006-05-23 | 2007-03-27 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Пептид, повышающий резистентность капилляров, фармацевтическая композиция на его основе и способ ее применения |
| RU2301678C1 (ru) * | 2006-05-30 | 2007-06-27 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Пептид, стимулирующий регенерацию нейронов центральной нервной системы, фармацевтическая композиция на его основе и способ ее применения |
| RU2301074C1 (ru) * | 2006-05-30 | 2007-06-20 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Пептид, обладающий иммуногеропротекторным действием, фармацевтическая композиция на его основе и способ ее применения |
| PT2120991E (pt) * | 2007-02-12 | 2014-05-02 | Biotempt Bv | Tratamento d a hemorragia traumática com oligopéptidos curtos |
| RU2464816C1 (ru) * | 2011-04-14 | 2012-10-27 | Общество с ограниченной ответственностью "Вилави" | Композиция биологически активных веществ, обладающая геропротекторной активностью, и способ комплексной коррекции возрастных изменений гормонального баланса, функций эпифиза и антиоксидантного статуса, включающий введение указанной композиции |
| WO2016190750A1 (en) * | 2015-05-22 | 2016-12-01 | The A2 Milk Company Limited | Beta-casein a2 and antioxidant capacity |
| CN115379847A (zh) * | 2020-04-15 | 2022-11-22 | 拉托科公司 | 用于调节代谢型谷氨酸受体5的合成肽 |
| KR102841388B1 (ko) * | 2022-08-30 | 2025-08-01 | 주식회사 제이포셀 | 항노화 펩타이드 및 황기 추출물을 포함하는 항노화 화장료 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH078273A (ja) * | 1993-06-14 | 1995-01-13 | Kurabo Ind Ltd | 接着性動物細胞の無血清培養法 |
| JPH0851980A (ja) * | 1994-08-11 | 1996-02-27 | Asahi Glass Co Ltd | 合成遺伝子およびこれを用いた癌転移阻害活性を有するペプチドの製造方法 |
| RU2099078C1 (ru) * | 1994-12-08 | 1997-12-20 | Акционерное общество закрытого типа "КОМКОН" | Средство, обладающее антистрессовым, стресспротекторным, ноотропным, антиалкогольным и антинаркотическим действием, способы профилактики и лечения с его использованием |
| RU2112512C1 (ru) * | 1995-09-22 | 1998-06-10 | Иванов Евгений Васильевич | Биологичеcки активная пищевая добавка "глутапирон", обладающая антиканцерогенным и геропротекторным действием |
| CA2307954C (en) * | 1997-04-03 | 2010-07-13 | California Institute Of Technology | Enzyme-medicated modification of fibrin for tissue engineering |
-
1999
- 1999-05-11 RU RU99108841/14A patent/RU2157233C1/ru not_active IP Right Cessation
-
2000
- 2000-01-20 EP EP00905499A patent/EP1179008B1/en not_active Expired - Lifetime
- 2000-01-20 WO PCT/RU2000/000012 patent/WO2000068255A2/en not_active Ceased
- 2000-01-20 AU AU27034/00A patent/AU769847C/en not_active Ceased
- 2000-01-20 JP JP2000616229A patent/JP3902406B2/ja not_active Expired - Fee Related
- 2000-01-20 ES ES00905499T patent/ES2259998T3/es not_active Expired - Lifetime
- 2000-01-20 IL IL14643200A patent/IL146432A0/xx active IP Right Grant
- 2000-01-20 CA CA002373128A patent/CA2373128C/en not_active Expired - Fee Related
- 2000-01-20 US US09/959,852 patent/US6727227B1/en not_active Expired - Fee Related
- 2000-01-20 DE DE60026826T patent/DE60026826T2/de not_active Expired - Lifetime
- 2000-01-20 AT AT00905499T patent/ATE321068T1/de active
-
2001
- 2001-11-11 IL IL146432A patent/IL146432A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6727227B1 (en) | 2004-04-27 |
| EP1179008B1 (en) | 2006-03-22 |
| ATE321068T1 (de) | 2006-04-15 |
| JP3902406B2 (ja) | 2007-04-04 |
| CA2373128C (en) | 2007-03-13 |
| ES2259998T3 (es) | 2006-11-01 |
| WO2000068255A2 (en) | 2000-11-16 |
| DE60026826D1 (de) | 2006-05-11 |
| AU2703400A (en) | 2000-11-21 |
| EP1179008A2 (en) | 2002-02-13 |
| AU769847C (en) | 2005-02-17 |
| DE60026826T2 (de) | 2007-04-12 |
| IL146432A (en) | 2007-06-03 |
| JP2003526622A (ja) | 2003-09-09 |
| CA2373128A1 (en) | 2000-11-16 |
| AU769847B2 (en) | 2004-02-05 |
| WO2000068255A3 (en) | 2001-06-14 |
| RU2157233C1 (ru) | 2000-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE321068T1 (de) | Alterungsschutztetrapeptid, dieses enthaltende pharmazeutische zusammensetzungen und seine verwendung | |
| IL149243A0 (en) | Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same | |
| IL140412A0 (en) | L-lys -l-glu dipeptides for pharmaceutical preparations | |
| HU0102272D0 (en) | Compositions and methods for stimulating gastrointestinal motilis | |
| ES2166270A1 (es) | Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona. | |
| UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
| WO2002030891A8 (en) | Aliphatic nitrogenous five-membered ring compounds | |
| PL356166A1 (en) | Pharmaceutical formulation containing tolterodine and its use | |
| NO20043871L (no) | Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid | |
| IL194500A0 (en) | Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application | |
| WO2005014032A3 (en) | Use of secretagogues like ghrelin in cancer cachexia and for stimulating appetite | |
| ATE513845T1 (de) | Peptidsubstanz mit immunogeroprotektiver wirkung, darauf basierende pharmazeutische zusammensetzung und verfahren zu ihrer anwendung | |
| WO2007136295A3 (en) | Peptide substance revealing a stress protective effect, pharmaceutical composition on its base and the method of its application | |
| NZ331256A (en) | Benzo[c]quinolizine derivatives, their preparation and use as 5 alpha-reductases inhibitors | |
| CA2425445A1 (en) | Tetrapeptide stimulating functional activity of hepatocytes, pharmacological substance on its basis and the method of its application | |
| CA2382654A1 (en) | Novel a-500359 derivatives | |
| RU2002125463A (ru) | Полипептидное соединение, способы его получения, фармацевтическая композиция и способ профилактики или лечения грибковых заболеваний | |
| AU2002351536A1 (en) | Analogs of human growth hormone-releasing hormone, their preparation and use | |
| RU94032285A (ru) | Цефалоспориновые соединения, способ их получения, фармацевтическая композиция | |
| MXPA02006034A (es) | Formas de dosis mucosaloral de apomorfina. | |
| AP9901559A0 (en) | Tricyclic 3-keto derivatives of 6-0-methylerythromycin. | |
| TR200201503T2 (tr) | Heterosiklik türevler. | |
| KR890005123A (ko) | 세펨 화합물 및 이의 제조방법 | |
| RU2010122457A (ru) | Синтетические пептиды, обладающие стресспротекторной активностью | |
| TH31615A (th) | โอพอยด์เพพไทด์ชนิดใหม่ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |